Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Familial Partial Lipodystrophy, Type 2
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Familial partial lipodystrophy, Dunnigan type (FPLD; Mendelian Inheritance in Man #151660), is an autosomal dominant disorder characterized by loss of s.c. fat from the extremities and trunk since puberty and predisposition to insulin resistance and its complications.
|
10843151 |
2000 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.
|
10739751 |
2000 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.
|
10655060 |
2000 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.
|
10587585 |
2000 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.
|
10587585 |
2000 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.
|
10739751 |
2000 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy.
|
11792809 |
2001 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy.
|
12196663 |
2002 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse.
|
11799477 |
2002 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene.
|
12015247 |
2002 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
Biomarker
|
disease |
CTD_human |
Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene.
|
14510863 |
2003 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
Biomarker
|
disease |
CTD_human |
Lack of mutations in LMNA, its promoter region, and the cellular retinoic acid binding protein II (CRABP II) in HIV associated lipodystrophy.
|
12844477 |
2003 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy.
|
12629077 |
2003 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations.
|
15372542 |
2004 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
Biomarker
|
disease |
CTD_human |
Long-term treatment experience in a subject with Dunnigan-type familial partial lipodystrophy: efficacy of rosiglitazone.
|
16241930 |
2005 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
Biomarker
|
disease |
BEFREE |
The Dunnigan syndrome [FPLD2 (familial partial lipodystrophy of the Dunnigan type)] is due to mutations in LMNA encoding the lamin A/C, belonging to the complex group of laminopathies that could comprise muscular and cardiac dystrophies, neuropathies and syndromes of premature aging.
|
16246048 |
2005 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The objective of the study was to carry out mutational analysis of LMNA in two sisters with a particularly severe FPLD2 phenotype.
|
16636128 |
2006 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660).
|
17250669 |
2007 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.
|
17711925 |
2007 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress.
|
19220582 |
2009 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Type 2 familial partial lipodystrophy (FPLD2) is characterised by loss of fat in the limbs and buttocks and results from mutations in the LMNA gene.
|
18805829 |
2009 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
Biomarker
|
disease |
CTD_human |
Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy.
|
19793595 |
2009 |
Familial Partial Lipodystrophy, Type 2
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The genetics of dilated cardiomyopathy.
|
20186049 |
2010 |